Interferon therapy can rapidly accelerate T1D development in genetically-susceptible individuals [121], indicating IFN-α/β may be able to initiate T1D by activating autoreactive lymphocytes. This evidence concerns the gene IFNA1 and type 1 diabetes mellitus.